Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 425
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02273271 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo | ||
| NCT00017498 | Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | ||
| NCT02214134 | SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access | ||
| NCT00766155 | Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer | ||
| NCT04097093 | Long-term Surival of GIST Patients ≥ 10 Years on Imatinib | ||
| NCT03005015 | Lenvatinib in Second Line Endometrial Carcinoma | ||
| NCT00041249 | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | ||
| NCT02436733 | Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM | ||
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | ||
| NCT00045032 | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer | ||
| NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | ||
| NCT00003212 | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | ||
| NCT01522612 | Colorectal Cancer (CRC) Cetuximab Elderly Frail | ||
| NCT00189553 | Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse | ||
| NCT00450892 | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | ||
| NCT00083096 | Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas | ||
| NCT01942603 | Minimal SN Tumor Burden | ||
| NCT04933942 | Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma | ||
| NCT02362594 | Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054) | ||
| NCT00004937 | Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT00022594 | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | ||
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT03770468 | Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma | ||
| NCT06326190 | 177Lu-DOTATATE for Recurrent Meningioma | ||
| NCT00052754 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | ||
| NCT03763422 | Trial in Low Grade Glioma Patients: Wait or Treat | ||
| NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer | ||
| NCT00003151 | Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | ||
| NCT00005826 | Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme | ||
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia | ||
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | ||
| NCT00014625 | E7070 in Treating Patients With Stage IV Melanoma | ||
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | ||
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | ||
| NCT00110123 | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma | ||
| NCT00379041 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | ||
| NCT00104936 | Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery | ||
| NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | ||
| NCT01838577 | Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study | ||
| NCT02470065 | Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. | ||
| NCT01290939 | Bevacizumab and Lomustine for Recurrent GBM | ||
| NCT00411541 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | ||
| NCT00005583 | Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | ||
| NCT00003152 | Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | ||
| NCT01508000 | Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases | ||
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | ||
| NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | ||
| NCT00003938 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | ||
| NCT01524926 | CREATE: Cross-tumoral Phase 2 With Crizotinib | ||
| NCT00006026 | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract |
